CEO - Taj Group
Taj Pharmaceuticals Limited
Pharmaceuticals Industries Ltd
Greece
Mumbai, Maharashtra, January 29, 2012 /India PRwire/ -- It's a fact that doesn't escape Mr.Abhishek Kumar Singh : At Taj Pharma (TPL), the big pharmaceutical firm he heads, about one-fifth of last year's net sales, some $1.7 billion, could, in the not-too-distant future, simply disappear. That's what happens when your two top-selling drugs lose patent protection. Singh also just saw his firm's longtime friend S.C. Jaiswal head of drug development leave to do charity work. So the CEO's big plan: replace the eventual lost sales from $80 million share buyback, the new palns include blood pressure and cancer treatments drug developments, respectively, with higher sales from...API manufacturing Division?
Taj Pharmaceuticals Limited